Equities researchers at StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report issued on Tuesday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Get Our Latest Stock Analysis on SenesTech
SenesTech Trading Down 0.3 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- What is a buyback in stocks? A comprehensive guide for investors
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Overbought Stocks Explained: Should You Trade Them?
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.